跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
immunotoxin
首页
药物
immunotoxin
immunotoxin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods for treating cancer using an immunotoxin
US 2007196366 A1
申请人: ZANGEMEISTER-WITTKE UWE
优先权: 2004
US
8 件公开
Methods for expression and purification of immunotoxins
CN 104356241 A
申请人: US GOVERNMENT
优先权: 2003
CN
EP
US
7 件公开
Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
US 2005118182 A1
申请人: PASTAN IRA H
优先权: 2004
US
7 件公开
Immunotoxin fusion proteins and means for expression thereof
US 7696338 B2
申请人: US HEALTH
优先权: 2004
US
6 件公开
Dual Specific Immunotoxin for Brain Tumor Therapy
US 2009269343 A1
申请人: UNIV DUKE
优先权: 2009
US
5 件公开
RECOMBINANT IMMUNOTOXIN COMPRISING A RIBOTOXIN OR RNASE
EP 4196593 A1
申请人: ATB THERAPEUTICS
优先权: 2020
CN
EP
US
WO
4 件公开
IMMUNOMODULATION BY ANTI-CD3 IMMUNOTOXINS TO TREAT CANCERS NOT UNIFORMLY BEARING SURFACE CD3
EP 3498305 A1
申请人: ANGIMMUNE LLC
优先权: 2012
CN
EP
US
4 件公开
BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS
EP 3927731 A4
申请人: UNIV COLORADO REGENTS
优先权: 2019
EP
US
4 件公开
Recombinant fusion protein and polynucleotide construct for immunotoxin production
US 8043621 B2
申请人: UNIV RAMOT
优先权: 2008
US
4 件公开
US 8597655 B2
申请人: BARNEA ITAY
优先权: 2011
US
2 件公开
COMPOSITIONS CONTAINING IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION FOR INDUCING IMMUNE TOLERANCE TO A GRAFT
EP 1171109 A1
申请人: US HEALTH
优先权: 1999
CN
EP
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈